REZI-20-037-1

N/A

Report date: 2025/01/26 17:49:22
NME

Base Information

Drug NameREZI-20-037-1
Drug Alias NameEHMT1/2 inhibitors (ProQinase/Mercachem)REZI-20-037-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EHMT2 inhibitorsEuchromatic Histone Lysine Methyltransferase 1 modulators
TargetsHistone-lysine N-methyltransferase EHMT2Euchromatic Histone Lysine Methyltransferase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMercachem Holding BV
China Registration ClassN/A

Develop Information

Active CompaniesMercachem Holding BVReaction Biology CorpGotham Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A